Skip to main content
Annals of Medicine and Surgery logoLink to Annals of Medicine and Surgery
. 2022 Mar 2;75:103449. doi: 10.1016/j.amsu.2022.103449

Ductal carcinoma in situ arising from fibroadenoma; a rare case with review of literature

Zuhair D Hammood a, Shvan H Mohammed b, Berwn A Abdulla a,b, Sami S Omar b,c, Sharo Naqar a,d, Abdulwahid M Salih a,d, Fahmi H Kakamad a,b,d,
PMCID: PMC8977904  PMID: 35386780

Abstract

Introduction

ibroadenoma (FA) is a common benign breast mass representing a group of hyperplastic breast lobules due to the deviation of normal development. This study aims to present a rare case of ductal carcinoma in situ (DCIS) associated with fibroadenoma.

Case report

A 49-year-old married female presents with a right breast mass for five years. Core needle biopsy diagnosed the specimen as cellular complex fibroadenoma. A breast-lumpectomy and the histopathological examination of the surgical specimen confirmed ductal carcinoma in-situ.

Discussion

Malignant changes within fibroadenomas typically happen at an older age, with the age of detection in the fifth decade. Complex fibroadenomas are more related to malignant transformation. Old age and strong family history are risk factors for malignant transformation of fibroadenomas.

Conclusion

Fibroadenomas are common benign tumors. They can rarely be associated with DCIS. Therefore, the risk of malignancy should always be kept in mind.

Keywords: Fibroadenoma, Benign tumors, DCIS, Breast cancer

Highlights

  • Fibroadenoma is a common benign breast mass.

  • It is known to be stimulated by many factors.

  • The peak incidence is the second and third decades of life

  • Cancer-associated fibroadenoma is extremely rare.

1. Introduction

Fibroadenoma (FA) is a common benign breast mass representing a group of hyperplastic breast lobules due to the deviation of normal development [1]. It is usually found as a single mass in the breast during the early reproductive years of a women's life [2]. Although it can occur at any age, the peak incidence is the second and third decades of life [3]. It is thought to be stimulated by many factors such as estrogen, progesterone, pregnancy, and lactation, and become atrophied during menopause [4]. It is a biphasic tumor comprised of stromal and epithelial elements [4]. The incidence ranges from 7% to 13% in the general population, and up to 20% present with bilateral and multiple masses [5]. The size of FA is directly proportional to the estrogen level, which may decrease in size or degenerate when estrogen effect decreases, particularly during the late fourth decade [6]. Cancer-associated fibroadenoma is extremely rare and found incidentally during pathological examination [7].

This report aims to present a rare case of ductal carcinoma in situ (DCIS) associated with FAs. SCARE guidelines were used with a brief literature review for the report preparation [8].

2. Case report

Patient Information: A 49-year-old married female presents with a right breast mass for five years. Her past medical history is notable for hypertension, for which she takes medication. Her family history is negative for breast cancer. Previously she underwent surgical resection of a mass in the same breast. The histopathological examination proved the resected mass to be a fibroadenoma.

Diagnostic Assessment: Focused physical examination of the right breast demonstrated a firm, smooth, ill non mobile mass. Mammography showed a lobulated well defined mass. Ultrasound of the breast showed a subareolar mass of (64*21mm) toward the 3 o'clock and 3mm away from the nipple with normal left breast. Magnetic resonance imaging (MRI) showed an oval-shaped mass of (55*35mm) at the subareolar region and toward 3 o'clock, 18mm away from the nipple and 28mm away from the chest wall. Core needle biopsy (FNA) diagnosed the specimen as cellular complex fibroadenoma.

Therapeutic Intervention: We resected the lump surgically and sent it for histopathological examination. The result confirmed ductal carcinoma in-situ (DCIS) confined within a fibroadenoma with clean surgical margin.

Follow-up and Outcome: We sent the patient to the oncologist, and they put her on Tamoxifen. During the postoperative follow-up, the patient seemed to be doing well and tolerating the medication fairly.

3. Discussion

It is uncertain whether FA increases the likelihood of breast cancer development [9]. Dupont et al. reported that the risk of developing invasive breast cancer (IBC) is about 2.17 times greater among patients with FA in comparison to non-fibroadenoma patients [10]. The incidence of carcinoma arising within FA is 0.02% [11]. Approximately two-thirds of carcinomas within FAs are lobular, and the remaining one-third are ductal or mixed [12]. Malignant changes within FAs typically occur at an older age, with the age of detection in the fifth decade [9,13]. Complex FAs have a higher tendency for malignant transformation than non-complex FAs [14]. As reported by Dupont et al. the risk is 3.10 times greater in patients with complex FAs than in non-complex ones, at about 1.89 times [10]. Other studies linked the presence of carcinoma to the degree of proliferation of the epithelium within the FA rather than the presence of fibroadenoma by itself [14]. Old age and strong family history are risk factors for the malignant transformation of FAs [15]. One of the significant indicators of malignant transformation in FAs is the increase in the size and thickness of the mass with advancing age [6]. Radiological studies may show suspicious findings indicating the presence of carcinoma arising from FAs [7]. Malignant changes can't be diagnosed preoperatively and need surgical intervention for diagnosis [16]. Sonographic examination of carcinomas arising from FAs appears irregular with irregular borders. They have extensive hypoechogenic shadowing with an echogenic halo and distort the surrounding tissue [7]. Ultrasound is superior for measuring the size of the tumor as it offers high-resolution imaging [6]. Mammography may demonstrate indistinct borders and microcalcifications, but it is hard to diagnose FAs harboring carcinoma using mammography alone [17]. The presence of microcalcifications on mammography is an excellent indicator of the malignant transformation of the tumor [11]. However, Ooe et al. reported a case of DCIS arising within a FA with a well-circumscribed, polygonal, and relatively iso-dense mass without the presence of microcalcifications [4]. The case reported by Luci et al. on mammography appeared as a partially well-circumscribed, single lesion with variable density [12]. However, on mammography, the lesion in the current study appeared as a lobulated and obscured mass with equal density. Through dynamic MRI, malignant changes can be differentiated from pure FAs through differences in vascularity [7]. FAs typically show on MRI a round, oval-shaped mass with a smooth margin and demonstrate a persistent enhancement until the late phase [15]. However, the dynamic MRI commonly shows a rapid early enhancement with variation in delayed enhancement when carcinoma is present [15]. In the current case, mammography observed a lobulated, obscured mass with equal density. MRI showed an oval-shaped mass.

Due to the rare status of the condition and its diagnosis being an incidental one, there isn't an exact management guidelines, and the treatment follows the malignant components of the FAs [3]. If the surgical margin is free of cancer, lumpectomy may be sufficient [7]. Management depends on the stage and the degree of metastasis (local or distant). If it is small, conservative management is sufficient in the form of lumpectomy or wide local excision with axillary lymph node dissection in the presence of local metastasis (N1) [17]. We treated our case with a breast lumpectomy. Prognosis depends on the grade and stage at diagnosis [4]. FAs can be diagnosed early through clinical presentations and screening programs, which results in early detection of any malignant transformation and a good prognosis [4]. However, studies show that 10% of patients presented with carcinoma in situ within an FA had recurrences or metastasis [17].

Although FAs are a common subtype of benign tumors, they rarely can be associated with DCIS. Therefore, the risk of malignancy should always be suspected. When malignant, the radiological features, management, and prognosis differ.

Ethical approval

The manuscript approved by ethical committee of Kscien organization.

Sources of funding

None is found.

Author contribution

Abdulwahid M. Salh: major contribution of the idea, literature review, final approval of the manuscript. Zuhair D. Hammood: Surgeon performing the operation, final approval of the manuscript. Fahmi H. Kakamad: literature review, writing the manuscript, final approval of the manuscript. Shvan H. Mohammed, Berwn A. Abdulla, Sami S. Omar, Sharo Naqar: literature review, final approval of the manuscript.

Consent

Written informed consent was obtained from the patients the patient's family for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Guarantor

Fahmi Hussein Kakamad is Guarantor of this submission.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Declaration of competing interest

None to be declared.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.amsu.2022.103449.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.doc (57KB, doc)

References

  • 1.El-Wakeel H., Umpleby H.C. A systematic review of fibroadenoma as a risk factor for breast cancer. Breast. 2003;12(5):302–307. doi: 10.1016/s0960-9776(03)00123-1. [DOI] [PubMed] [Google Scholar]
  • 2.Dent D.M., Cant P.J. Fibroadenoma. World J. surg. 1989;13(6):706–710. doi: 10.1007/BF01658418. [DOI] [PubMed] [Google Scholar]
  • 3.Zeeshan S., Siddique S., Riaz N. Ductal Carcinoma-in-situ within fibroadenoma of the breast: a case report with literature review. Int. J. Case Rep. Images. 2018;9 100916Z01SZ2018. [Google Scholar]
  • 4.Ooe A., Takahara S., Sumiyoshi K., Yamamoto H., Shiba E., Kawai J. Preoperative diagnosis of ductal carcinoma in situ arising within a mammary fibroadenoma: a case report. Jpn. J. Clin. Oncol. 2011;41(7):918–923. doi: 10.1093/jjco/hyr075. [DOI] [PubMed] [Google Scholar]
  • 5.Dialani V., Chansakul T., Lai K.C., Gilmore H., Sayegh N.Y., Slanetz P.J. Enlarging biopsy-proven fibroadenoma: is surgical excision necessary? Clin. Imag. 2019;57:35–39. doi: 10.1016/j.clinimag.2019.03.014. [DOI] [PubMed] [Google Scholar]
  • 6.Shojaku H., Hori R., Yoshida T., Matsui K., Shimada K., Takayanagi N., et al. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: a case report. Medicine. 2021;100(10) doi: 10.1097/MD.0000000000024023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wu Y.T., Wu H.K., Chen S.T., Chen C.J., Chen D.R., Lai H.W. Fibroadenoma progress to ductal carcinoma in situ, infiltrating ductal carcinoma, and lymph node metastasis? Report an unusual case. J. Surg. Case Rep. 2017;(5):64. doi: 10.1093/jscr/rjx064. 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Agha R.A., Franchi T., Sohrabi C., Mathew G., Kerwan A., Thoma A., et al. The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226–230. doi: 10.1016/j.ijsu.2020.10.034. [DOI] [PubMed] [Google Scholar]
  • 9.Frisch O., De Jager L.J., Otto M., Downs J., Malherbe F. A teenager with ductal carcinoma in situ arising in a fibroadenoma: a case report. S. Afr. J. Surg. 2018;56(4):30–33. [Google Scholar]
  • 10.Dupont W.D., Page D.L., Parl F.F., Vnencak-Jones C.L., Plummer W.D., Jr., Rados M.S., et al. Long-term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med. 1994;331(1):10–15. doi: 10.1056/NEJM199407073310103. [DOI] [PubMed] [Google Scholar]
  • 11.You J.K., Kim Y.J., Kim B., Kim E.K. Ductal carcinoma in situ within a fibroadenoma: microcalcifications identified on mammography play a crucial role in diagnosis. J. Korean Soc. Radiol. 2016;74(6):361–364. [Google Scholar]
  • 12.Gashi-Luci L.H., Limani R.A., Kurshumliu F.I. Invasive ductal carcinoma within fibroadenoma: a case report. Cases J. 2009;2(1):1–4. doi: 10.1186/1757-1626-2-174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Marumoto A., Steinemann S., Furumoto N., Woodruff S. An uncommon pairing of common tumors: case report of ductal carcinoma in situ within fibroadenoma. Hawai‘i J. Med. Public Health. 2019;78(2):39. [PMC free article] [PubMed] [Google Scholar]
  • 14.El-Essawy M., AL Haidary A., Khan A.L. Ductal carcinoma in situ (DCIS) in breast fibroadenoma. Egypt. J. Radiol. Nuclear Med. 2020;51:1–7. [Google Scholar]
  • 15.Kato F., Omatsu T., Matsumura W., Takahashi M., Hosoda M., Takahashi H., et al. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. Magn. Reson. Med. Sci. 2011;10(2):129–132. doi: 10.2463/mrms.10.129. [DOI] [PubMed] [Google Scholar]
  • 16.Borecky N., Rickard M. Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms. J. Med. Imag. Rad. oncol. 2008;52(1):64–67. doi: 10.1111/j.1440-1673.2007.01913.x. [DOI] [PubMed] [Google Scholar]
  • 17.Khandelwal R., Tandon M., Yashwant K., Kulshreshtha P., Aeron T., Bhatnagar D., et al. Carcinoma developing in a fibroadenoma in a woman with a family history of breast cancer: a case report and review of the literature. Cases J. 2009;2(1):1–4. doi: 10.1186/1757-1626-2-9348. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.doc (57KB, doc)

Articles from Annals of Medicine and Surgery are provided here courtesy of Wolters Kluwer Health

RESOURCES